PMID: 9648878Jul 2, 1998Paper

Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion

Journal of Neurochemistry
D S CassarinoJ P Bennett

Abstract

Sporadic Parkinson's disease is associated with a defect in the activity of complex I of the mitochondrial electron transport chain. This electron transport chain defect is transmitted through mitochondrial DNA, and when expressed in host cells leads to increased oxygen free radical production, increased antioxidant enzyme activities, and increased susceptibility to programmed cell death. Pramipexole, a chemically novel dopamine agonist used for the treatment of Parkinson's disease symptoms, possesses antioxidant activity and is neuroprotective toward substantia nigral dopamine neurons in hypoxic-ischemic and methamphetamine models. We found that pramipexole reduced the levels of oxygen radicals produced by methylpyridinium ion (MPP+) both when incubated with SH-SY5Y cells and when perfused into rat striatum. Pramipexole also exhibited a concentration-dependent inhibition of opening of the mitochondrial transition pore induced by calcium and phosphate or MPP+. These results suggest that pramipexole may be neuroprotective in Parkinson's disease by attenuating intracellular processes such as oxygen radical generation and the mitochondrial transition pore opening, which are associated with programmed cell death.

Citations

Jun 23, 2001·Drugs & Aging·W D Le, J Jankovic
Dec 5, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A H V Schapira
Jul 23, 2003·CNS Drugs·Silvia MandelMoussa B H Youdim
May 14, 2005·Antioxidants & Redox Signaling·Clifford W Shults
Sep 27, 2006·Neurotoxicity Research·Keith ChiassonMaria-Grazia Martinoli
Sep 22, 2006·American Journal of Therapeutics·Sheng Chen, Weidong Le
Apr 18, 2008·Expert Review of Neurotherapeutics·Mitsutoshi Yamamoto, Anthony H V Schapira
Nov 9, 2011·The Neurologist·Maria Trinidad HerreroGurutz Linazasoro
Nov 4, 2015·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·N V Titova
Feb 27, 2019·Journal of Cellular Physiology·Mehrdad AghaeiVahid Khori
Mar 22, 2020·British Journal of Pharmacology·Daniela BuonvicinoAlberto Chiarugi
Oct 3, 2003·Expert Opinion on Pharmacotherapy·Janet RomrellMichael S Okun
Feb 10, 2006·Expert Review of Neurotherapeutics·Ubaldo Bonuccelli, Nicola Pavese
Apr 9, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Peter A LeWitt, Danette C Taylor
Apr 11, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A H V Schapira
Oct 21, 2010·Journal of Clinical Pharmacology·Michael E BozikEvan W Ingersoll
Oct 22, 2009·Current Medical Research and Opinion·Stefan Albrecht, Erich Buerger
Feb 9, 2006·Journal of Neurochemistry·Mahmoud M IravaniAnthony H Schapira
Mar 21, 2017·British Journal of Pharmacology·Mirko MuzziAlberto Chiarugi
Dec 8, 2019·Neurochemical Research·Chao DengLi Dai
Dec 1, 2004·Journal of Neurochemistry·Mei GuAnthony H V Schapira
Jun 22, 2006·Neurotoxicity Research·M GerlachP Riederer
Jun 22, 2006·Neurotoxicity Research·M F BealT Archer
Feb 7, 2002·Expert Opinion on Pharmacotherapy·Kevin M Biglan, Robert G Holloway
Jan 13, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Iqbal SayeedDetlef Siemen
Apr 1, 2003·Annals of Neurology·Karl Kieburtz
Aug 3, 2011·Expert Opinion on Emerging Drugs·Ali Aamer Habib, Hiroshi Mitsumoto
Sep 12, 2015·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·E A KatuninaA N Boiko

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.